← Eichor
Condition: Scn1A Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Scn1A

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Study to Evaluate the Safety and Pharmacokinetics of RC001 in Children With Dravet Syndrome
EARLY_Phase 1 · 1 location(s) · Second Affiliated Hospital of Guangzhou Medical University · NCT07675746Registry and Natural History of Epilepsy-Dyskinesia Syndromes
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06967727Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight
Phase N/A · 2 location(s) · Simons Searchlight · NCT01238250SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom
Phase N/A · 1 location(s) · NHS Greater Glasgow and Clyde · NCT06504511A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06585605A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndro
Phase 1/Phase 2 · 14 location(s) · Encoded Therapeutics · NCT05419492Longitudinal Study of Phenotypic and Developmental Severity in Patients With Dravet Syndrome With SCN1A Gene Mutation
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07251673GABA Biomarkers in Dravet Syndrome
Phase N/A · 1 location(s) · Cook Children's Health Care System · NCT05651204
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.